105 related articles for article (PubMed ID: 3698050)
1. Phase II evaluation of mitoguazone in cancers of the esophagus, stomach, and pancreas: a Southeastern Cancer Study Group Trial.
Ravry MJ; Omura GA; Hill GJ; Bartolucci AA; Velez-Garcia E
Cancer Treat Rep; 1986 Apr; 70(4):533-4. PubMed ID: 3698050
[No Abstract] [Full Text] [Related]
2. Mitoguazone in advanced squamous cell carcinoma of head and neck origin: a phase II trial of the Southeastern Cancer Study Group.
Luedke DW; Maddox W; Birch R; Velez-Garcia E; Schleuter J
Cancer Treat Rep; 1986 Apr; 70(4):529-30. PubMed ID: 3698048
[No Abstract] [Full Text] [Related]
3. Phase II study of methyl-GAG in the treatment of esophageal carcinoma.
Kelsen D; Chapman R; Bains M; Heelan R; Dukeman M; Golbey R
Cancer Treat Rep; 1982 Jun; 66(6):1427-9. PubMed ID: 7083245
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of mitoguazone in patients with advanced head and neck cancer.
Thongprasert S; Bosl GJ; Geller NL; Wittes RE
Cancer Treat Rep; 1984 Oct; 68(10):1301-2. PubMed ID: 6525604
[No Abstract] [Full Text] [Related]
5. Phase II study of mitoguazone in pancreatic cancer: a Southwest Oncology Group Study.
Inamasu MS; Oishi N; Chen TT; Kraut EH; Grozea PN; Costanzi JJ; Bonnet JD
Cancer Treat Rep; 1986 Apr; 70(4):531-2. PubMed ID: 3698049
[No Abstract] [Full Text] [Related]
6. Phase II evaluation of cisplatin in squamous carcinoma of the esophagus: a Southeastern Cancer Study Group trial.
Ravry MJ; Moore MR; Omura GA; Esseese I; Bartolucci A
Cancer Treat Rep; 1985 Dec; 69(12):1457-8. PubMed ID: 4075322
[No Abstract] [Full Text] [Related]
7. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of mitoguazone in patients with advanced squamous cell carcinoma of the head and neck.
Perry DJ; Crain SM; Weltz MD; Wilson JP; Davis RK; Woolley PV; Forastiere AA; Taylor HG; Weiss RB
Cancer Treat Rep; 1983 Jan; 67(1):91-2. PubMed ID: 6616496
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas.
Ajani JA; Ilson DH; Kelsen DP
Semin Oncol; 1996 Oct; 23(5 Suppl 12):55-8. PubMed ID: 8941411
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of methyl-GAG in advanced renal cancer.
Zeffren J; Yagoda A; Watson RC; Natale RB; Blumenreich MS; Chapman R; Howard J
Cancer Treat Rep; 1981; 65(5-6):525-7. PubMed ID: 6263478
[No Abstract] [Full Text] [Related]
11. Phase II evaluation of mitoguazone in metastatic hormone-resistant prostate cancer: a Southeastern Cancer Study Group trial.
Moore MR; Graham SD; Birch R; Irwin L
Cancer Treat Rep; 1987 Jan; 71(1):89-90. PubMed ID: 3791273
[No Abstract] [Full Text] [Related]
12. Phase II trial of methylglyoxal-bis-(guanylhydrazone) in non-small-cell lung cancer.
Chapman R; Kelsen D; Gralla R; Itri L; Casper E; Young C; Golbey R
Cancer Clin Trials; 1981; 4(4):389-91. PubMed ID: 6274532
[TBL] [Abstract][Full Text] [Related]
13. [Phase II trial of mitoguazone in patients with recurrent extensive cervicofacial tumors].
Coninx P; Nasca S; Jezekova D; Roelandt H; Morel M; Legros M; Cattan A
Bull Cancer; 1985; 72(2):153-4. PubMed ID: 4005436
[No Abstract] [Full Text] [Related]
14. Phase II evaluation of mitoxantrone in advanced carcinoma of the stomach: a Southeastern Cancer Study Group Trial.
DeSimone PA; Gams R; Birch R
Cancer Treat Rep; 1986 Aug; 70(8):1043-4. PubMed ID: 3524836
[No Abstract] [Full Text] [Related]
15. Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junction.
Safran H; Akerman P; Cioffi W; Gaissert H; Joseph P; King T; Hesketh PJ; Wanebo H
Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):53-7. PubMed ID: 10210540
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin, vindesine, and mitoguazone in the treatment of esophageal cancer.
Kelsen DP; Fein R; Coonley C; Heelan R; Bains M
Cancer Treat Rep; 1986 Feb; 70(2):255-9. PubMed ID: 3948190
[TBL] [Abstract][Full Text] [Related]
17. Phase II evaluation of aclarubicin in lung cancer: a Southeastern Cancer Study Group Trial.
Kramer BS; Birch R; Gockerman JP; Greco A; Prestridge K
Cancer Treat Rep; 1986 Jun; 70(6):803-4. PubMed ID: 3015404
[No Abstract] [Full Text] [Related]
18. Phase II trial of mitoguazone in patients with relapsed small cell carcinoma of the lung.
Scher H; Chapman R; Kelsen D; Gralla R; Wittes R
Cancer Treat Rep; 1984 Mar; 68(3):561-2. PubMed ID: 6322989
[No Abstract] [Full Text] [Related]
19. [A synchronous double cancer of esophagus and stomach treated with 5-fluorouracil and consecutive low-dose cisplatin].
Kondo K; Akiyama S; Nonami T; Kasai Y; Hibi K; Ito K; Takagi H
Gan To Kagaku Ryoho; 1995 Oct; 22(12):1839-42. PubMed ID: 7574819
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy for gastro-oesophageal cancer with epirubicin, cisplatin and fluorouracil: a single-centre experience.
Strickland AH; Karapetis CS; Yip D; Harper PG
Clin Oncol (R Coll Radiol); 2001; 13(1):66. PubMed ID: 11292143
[No Abstract] [Full Text] [Related]
[Next] [New Search]
